News

Location: Home > News

2026-03-26

【In Stock】From "Niche Raw Material" to "Clinical Darling": The Comeback Story of Cinobufagin!

We carefully select and launch the popular Sinomenine Impurity Reference Standards to help improve the quality of drugs!...

26

2026-03

More

2026-03-26

【Leaders' Visit】We warmly welcome the delegation from the Changzhou Science and Technology Bureau to visit and provide guidance at Changzhou Xianglong!

On the afternoon of March 13, a delegation led by officials from the Changzhou Science and Technology Bureau, the Changzhou Productivity Development Center, and the Xinnbei District Science and Technology Bureau visited Changzhou Xianglong Pharmaceutical Technology Co., Ltd. The ...

26

2026-03

More

2025-12-03

【Official Announcement, Official Recognition】Changzhou Xianglong has been recognized by EDQM and has become the sole global service provider for EP standard substances in China!

Recently, the latest publication of "Global EP Standard Substance Service Provider Directory" by the European Directorate for the Quality of Medicines (EDQM) was officially released. It clearly states: Changzhou Xianglong Pharmaceutical Technology Co., Ltd. is the only Chinese co...

03

2025-12

More

2025-11-06

[Major Update] The product labels and COAs have been comprehensively upgraded. Click to unlock the details of the update!

Thank you for your continuous support and trust in Changzhou Xianglong. To enhance the standardization of product information management, ensure compliance, and achieve traceability of all product lifecycle data, our company has decided to systematically update the labels and COA...

06

2025-11

More

2025-10-10

【Xianglong Class】Cyclosporine: The "Immune Gatekeeper" for Organ Transplantation!

The imported cyclosporine is a potent immunosuppressant, mainly used to prevent rejection reactions after organ transplantation and to treat severe autoimmune diseases. It works by inhibiting the activity of T lymphocytes and reducing the aggressiveness of the immune system. It m...

10

2025-10

More

E-mail